Acura Pharma Balance Sheet - Annual (OTCMKTS:ACUR)

Add to My Stocks
$0.52 $0.02 (3.7%) ACUR stock closing price Mar 21, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Acura Pharma balance sheet. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Acura Pharma stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Acura Pharma balance sheet indicates an asset turnover ratio of 0.05 and debt to equity ratio of 2.26. Also check Acura Pharma revenue and Acura Pharma operating cash flow for the same period.

View latest 10 year balance sheet data to check Acura Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Marketable Securities-10.83M11.32M13.73M19.94M---5.03M
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets--------2.92M
Total Current Assets
Property Plant & Equipment2.8M2.75M2.75M2.61M2.59M2.48M2.37M2.55M2.38M
Accumulated Depreciation1.94M1.74M1.79M1.67M1.54M1.43M1.32M1.39M1.3M
Net Property Plant & Equipment
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets---------
Total Assets
Notes Payable---------
Accounts Payable---------
Current Portion Long-Term Debt2.37M2.32M1.75M------
Current Portion Capital Leases---------
Accrued Expenses---------
Income Taxes Payable---------
Other Current Liabilities-------1.55M4.63M
Total Current Liabilities
Deferred Taxes/Income---------
Convertible Debt--7.96M------
Long-Term Debt2.97M5.43M-9.6M-----
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus375.76M375.15M366.89M366.53M362.42M361.73M359.83M352.69M344.02M
Retained Earnings-374.69M-367.31M-362.32M-349.11M-335.21M-325.54M-335.92M-323.22M-307.38M
Treasury Stock---------
Other Liabilities--0.06M-0.01M--0.04M----
Shareholders Equity1.18M7.9M5.05M17.92M27.63M36.64M24.34M29.91M37.06M
Total Liabilities & Shareholders Equity8.2M16.96M16.19M28.63M29.05M37.17M25.49M31.91M42.96M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Acura Pharma stock price by looking at Acura Pharma historical stock prices. One can compare PE with industry average by looking at the Acura Pharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Acura Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ACUR stock as of 2016 is $8.2M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Acura Pharma is $7.02M. Shareholders' equity comes under liabilities as it is money the company owes the holders of ACUR stock.

Acura Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio